| Mrs Pamela Sue Nethery, APRN, BC, FNP | |
|
327 Capital Ave Ne, Battle Creek, MI 49017-3924 | |
| (269) 969-6040 | |
| (269) 969-6041 |
| Full Name | Mrs Pamela Sue Nethery |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 327 Capital Ave Ne, Battle Creek, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083797518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 4704136276 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela Sue Nethery, APRN, BC, FNP 15312 Brooklodge Rd., Hickory Corners, MI 49060-9740 Ph: (269) 671-4850 | Mrs Pamela Sue Nethery, APRN, BC, FNP 327 Capital Ave Ne, Battle Creek, MI 49017-3924 Ph: (269) 969-6040 |
News Archive
CQ Politics: "House Speaker Nancy Pelosi made another bid to solidify support for Democrats' ambitious health care plans Friday, pledging to move aggressively to close the "doughnut hole" in Medicare drug coverage.
Multi-faceted pain research discoveries within the last decade are bringing new hope for the estimated 100 million Americans with chronic pain. Unfortunately, translation of these scientific advances into clinical practice could be stalled without sufficient funding for both basic science and clinical pain research, according to the American Pain Society.
Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
National bans on highly hazardous pesticides can be a cost-effective and affordable intervention for reducing suicide deaths in countries with a high burden of suicides attributable to pesticides, according to a new study published in The Lancet Global Health today.
› Verified 3 days ago
Chantelle Remenak, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 181 Emmett St W, Battle Creek, MI 49037 Phone: 269-966-2600 | |
Jessica L Cotton, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5161 B Dr S, Suite A, Battle Creek, MI 49015 Phone: 269-969-6099 Fax: 269-969-6089 | |
Angela K Schutte, RXN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 675 Wagner Dr, Battle Creek, MI 49017 Phone: 269-969-6244 | |
Mrs. Holly Marie Weaver, A-GNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1125 Michigan Ave E, Ste. 5, Battle Creek, MI 49014 Phone: 269-969-6014 | |
Mohiuddin Rasel, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49037 Phone: 269-966-5600 | |
Dr. Wen Hsin Ku, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 Michigan Ave W Ste 103, Battle Creek, MI 49017 Phone: 269-441-9300 | |
Ms. Irene Nancy Meholic, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49015 Phone: 269-966-5600 |